{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:12:15Z","timestamp":1790871135417,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"vor","delay-in-days":2839,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1194\/jlr.m030528","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T00:39:33Z","timestamp":1351903173000},"page":"134-151","source":"Crossref","is-referenced-by-count":222,"title":["AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism"],"prefix":"10.1016","volume":"54","author":[{"given":"Stephen L.","family":"Pinkosky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Filippov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rai Ajit K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Hanselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl D.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay T.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Spahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley F.","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob L.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Naples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khosrow","family":"Adeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M030528_bib1","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics\u20132007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation."},{"key":"10.1194\/jlr.M030528_bib2","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M030528_bib4","first-page":"35","article-title":"The future of lipid-lowering therapy: the big picture","volume":"61","author":"Kastelein","year":"2003","journal-title":"Neth. J. Med."},{"key":"10.1194\/jlr.M030528_bib5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/BOR.0b013e328314b7b4","article-title":"Genetic predisposition to statin myopathy","volume":"20","author":"Vladutiu","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1194\/jlr.M030528_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cjca.2011.05.007","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference","volume":"27","author":"Mancini","year":"2011","journal-title":"Can. J. Cardiol."},{"key":"10.1194\/jlr.M030528_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacl.2011.05.005","article-title":"Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia","volume":"5","author":"Harris","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.M030528_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen","year":"2012","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.M030528_bib10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA."},{"key":"10.1194\/jlr.M030528_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archinternmed.2011.625","article-title":"Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative","volume":"172","author":"Culver","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1194\/jlr.M030528_bib12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1194\/jlr.M400018-JLR200","article-title":"Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome","volume":"45","author":"Cramer","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib13","unstructured":"Hanselman, J. C., Bradshaw, C. D., Brant, A. F., Cramer, C. T., Hurley, T. R., Pinkosky, S. L., Spahr, M. A., Washburn, J. G., Newton, R. S., Srivastava, R. A. K., . 2011. ETC-1002 reduces circulating and hepatic triglyceride content and improves glycemic control in KKAy mice. (Abstract 554 in ATVB 2011 Scientific Sessions, Chicago, IL, April 28\u201330, 2011)."},{"key":"10.1194\/jlr.M030528_bib14","unstructured":"Cramer, C. T., Srivastava, R. A., Lutostanski, J., Bisgaier, C. L., Newton, R. S., . 2011. ETC-1002: a novel small molecule inhibitor of lipogenesis improves plasma lipid profile and inhibits atherosclerosis progression in LDLr\u2212\/\u2212 Mouse by a lipid-dependent and independent mechanism. (Abstract 404 in ATVB 2011 Scientific Sessions, Chicago, IL, April 28\u201330, 2011)."},{"key":"10.1194\/jlr.M030528_bib15","doi-asserted-by":"crossref","first-page":"E1625","DOI":"10.1016\/S0735-1097(12)61626-X","article-title":"ETC-1002 lowers LDL-C and beneficially modulates other cardio-metabolic risk factors in hypercholesterolemic subjects with either normal or elevated triglycerides","volume":"59","author":"Ballantyne","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.M030528_bib16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/BF02623623","article-title":"Isolation and culture of hepatocytes from the cynomolgus monkey (Macaca fascicularis)","volume":"26","author":"Ulrich","year":"1990","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"10.1194\/jlr.M030528_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0003-2697(77)90046-X","article-title":"Quantitative extraction of microgram amounts of lipid from cultured human cells","volume":"83","author":"Slayback","year":"1977","journal-title":"Anal. Biochem."},{"key":"10.1194\/jlr.M030528_bib18","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1194\/jlr.D900008-JLR200","article-title":"A novel direct homogeneous assay for ATP citrate lyase","volume":"50","author":"Ma","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib19","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1194\/jlr.M003335","article-title":"Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice","volume":"51","author":"Wang","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.22774","article-title":"Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice","volume":"49","author":"Wang","year":"2009","journal-title":"Hepatology."},{"key":"10.1194\/jlr.M030528_bib21","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1046\/j.1432-1327.2001.02140.x","article-title":"Multisite control of the Crabtree effect in ascites hepatoma cells","volume":"268","author":"Rodr\u00edguez-Enr\u00edquez","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.M030528_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants","volume":"97","author":"Marroquin","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1194\/jlr.M030528_bib23","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.51.7.2199","article-title":"Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome","volume":"51","author":"Buhl","year":"2002","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M030528_bib24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-2275(20)35728-X","article-title":"Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans","volume":"34","author":"Dietschy","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0005-2760(91)90080-2","article-title":"Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma","volume":"1083","author":"Quig","year":"1991","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M030528_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-2275(20)32397-X","article-title":"Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes","volume":"41","author":"Taghibiglou","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1172\/JCI113321","article-title":"Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster","volume":"81","author":"Spady","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M030528_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-2999(01)01249-3","article-title":"High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists","volume":"427","author":"Wang","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1194\/jlr.M030528_bib33","doi-asserted-by":"crossref","first-page":"e14205","DOI":"10.1371\/journal.pone.0014205","article-title":"Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice","volume":"5","author":"He","year":"2010","journal-title":"PLoS ONE."},{"key":"10.1194\/jlr.M030528_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2012.06.024","article-title":"Anti-diabetic and anti-adipogenic effects of a novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice","volume":"691","author":"Park","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1194\/jlr.M030528_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0003-9861(69)90532-3","article-title":"Tricarballylate and hydroxycitrate: substrate and inhibitor of ATP: citrate oxaloacetate lyase","volume":"135","author":"Watson","year":"1969","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.M030528_bib40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0021-9258(18)62460-3","article-title":"Effect of (-)-hydroxycitrate on fatty acid synthesis by rat liver in vivo","volume":"246","author":"Lowenstein","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1432-1033.1973.tb03038.x","article-title":"Inhibition of enzymes which interact with citrate by (\u2013)hydroxycitrate and 1,2,3,-tricarboxybenzene","volume":"38","author":"Cheema-Dhadli","year":"1973","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.M030528_bib42","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0021-9258(19)40033-1","article-title":"Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age","volume":"265","author":"Elshourbagy","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-5793(72)80266-7","article-title":"Inhibition of cholesterol synthesis by (-)-hydroxycitrate in perfused rat liver. Evidence for an extramitochondrial mevalonate synthesis from acetyl coenzyme A","volume":"22","author":"Barth","year":"1972","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.M030528_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02532964","article-title":"Hupolipidemic activity of (-)-hydroxycitrate","volume":"12","author":"Hamilton","year":"1977","journal-title":"Lipids."},{"key":"10.1194\/jlr.M030528_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0003-9861(72)90025-2","article-title":"Inhibition of lipogenesis in rat liver by (-)-hydroxycitrate","volume":"150","author":"Sullivan","year":"1972","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.M030528_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/bj2720181","article-title":"The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2","volume":"272","author":"Berkhout","year":"1990","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.M030528_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/bj3340113","article-title":"The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076","volume":"334","author":"Pearce","year":"1998","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.M030528_bib49","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science."},{"key":"10.1194\/jlr.M030528_bib50","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1038\/onc.2010.206","article-title":"Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility","volume":"29","author":"Jeninga","year":"2010","journal-title":"Oncogene."},{"key":"10.1194\/jlr.M030528_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cmet.2011.07.007","article-title":"The logic linking protein acetylation and metabolism","volume":"14","author":"Guarente","year":"2011","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.M030528_bib52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(87)80292-2","article-title":"A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis","volume":"223","author":"Carling","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.M030528_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1113\/jphysiol.2006.107318","article-title":"Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes","volume":"574","author":"Watt","year":"2006","journal-title":"J. Physiol."},{"key":"10.1194\/jlr.M030528_bib64","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1096\/fj.10-159723","article-title":"Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP\/ATP ratio","volume":"24","author":"Liu","year":"2010","journal-title":"FASEB J."},{"key":"10.1194\/jlr.M030528_bib65","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI34260","article-title":"Insulin sensitivity: modulation by nutrients and inflammation","volume":"118","author":"Schenk","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M030528_bib66","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1172\/JCI58577","article-title":"Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity","volume":"121","author":"Galic","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M030528_bib67","doi-asserted-by":"crossref","first-page":"b1668","DOI":"10.1136\/bmj.b1668","article-title":"Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance","volume":"338","author":"Adler","year":"2009","journal-title":"BMJ."},{"key":"10.1194\/jlr.M030528_bib68","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.M030528_bib69","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA."},{"key":"10.1194\/jlr.M030528_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib71","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.M030528_bib72","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M030528_bib73","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature03967","article-title":"The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism","volume":"437","author":"Koo","year":"2005","journal-title":"Nature."},{"key":"10.1194\/jlr.M030528_bib76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/35093050","article-title":"Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1","volume":"413","author":"Yoon","year":"2001","journal-title":"Nature."},{"key":"10.1194\/jlr.M030528_bib77","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2337\/diabetes.50.7.1515","article-title":"Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase","volume":"50","author":"Leclerc","year":"2001","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M030528_bib78","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1074\/jbc.M107895200","article-title":"Mechanism for fatty acid \u201csparing\u201d effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase","volume":"277","author":"Kawaguchi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1432-1033.1988.tb14201.x","article-title":"Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase","volume":"175","author":"Munday","year":"1988","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.M030528_bib80","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0003-9861(74)90058-7","article-title":"Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation","volume":"164","author":"Carlson","year":"1974","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.M030528_bib81","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/0026-0495(87)90101-6","article-title":"Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review","volume":"36","author":"Beg","year":"1987","journal-title":"Metabolism."},{"key":"10.1194\/jlr.M030528_bib82","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s002040050633","article-title":"Species differences in induction of hepatic enzymes by BM 17.0744, an activator of peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"73","author":"Meyer","year":"1999","journal-title":"Arch. Toxicol."},{"key":"10.1194\/jlr.M030528_bib84","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7827(01)00004-2","article-title":"The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects","volume":"40","author":"Bremer","year":"2001","journal-title":"Prog. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib91","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1016\/S0021-9258(19)86677-2","article-title":"Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis","volume":"254","author":"McCune","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib92","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1021\/jm00216a009","article-title":"5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids","volume":"20","author":"Parker","year":"1977","journal-title":"J. Med. Chem."},{"key":"10.1194\/jlr.M030528_bib93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-2275(20)34199-7","article-title":"A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor","volume":"39","author":"Bisgaier","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib100","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0022-2275(20)32433-0","article-title":"Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation","volume":"40","author":"Rasp\u00e9","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib101","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","article-title":"The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes","volume":"20","author":"Vega","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1194\/jlr.M030528_bib102","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature."},{"key":"10.1194\/jlr.M030528_bib103","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction","volume":"423","author":"Puigserver","year":"2003","journal-title":"Nature."},{"key":"10.1194\/jlr.M030528_bib104","doi-asserted-by":"crossref","first-page":"27495","DOI":"10.1074\/jbc.M304112200","article-title":"AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.M030528_bib106","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2337\/db11-0248","article-title":"Suppression of FoxO1 activity by long-chain fatty acyl analogs","volume":"60","author":"Zatara","year":"2011","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M030528_bib3","doi-asserted-by":"crossref","first-page":"27i","DOI":"10.1016\/S0002-9149(03)00506-X","article-title":"Effective strategies for long-term statin use","volume":"92","author":"Fonarow","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.M030528_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11883-009-0077-8","article-title":"Management of the patient with statin intolerance","volume":"12","author":"Vandenberg","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1194\/jlr.M030528_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2010.10.033","article-title":"Evaluation of anti-atherosclerotic activities of PPAR-alpha, PPAR-gamma, and LXR agonists in hyperlipidemic atherosclerosis-susceptible F(1)B hamsters","volume":"214","author":"Srivastava","year":"2011","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M030528_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-010-0573-8","article-title":"Anti-hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster","volume":"345","author":"Srivastava","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1194\/jlr.M030528_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1388-1981(01)00156-1","article-title":"Regulation of lipid metabolism and gene expression by fenofibrate in hamsters","volume":"1533","author":"Guo","year":"2001","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M030528_bib31","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0022-2275(20)42612-4","article-title":"Effects of dietary cholesterol and fatty acids on plasma cholesterol level and hepatic lipoprotein metabolism","volume":"31","author":"Ohtani","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib34","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/ijo.2008.60","article-title":"Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase","volume":"32","author":"Jang","year":"2008","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1194\/jlr.M030528_bib35","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.2337\/db11-0578","article-title":"Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo","volume":"61","author":"Konstantopoulos","year":"2012","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M030528_bib36","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/db11-0194","article-title":"Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance","volume":"60","author":"Lee","year":"2011","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M030528_bib37","doi-asserted-by":"crossref","first-page":"15333","DOI":"10.1074\/jbc.M110.100263","article-title":"Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice","volume":"285","author":"Li","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0003-9861(72)90054-9","article-title":"3- -Hydroxysterol synthesis by the liver","volume":"150","author":"Brunengraber","year":"1972","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.M030528_bib53","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/j.1432-1033.2004.04151.x","article-title":"Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids","volume":"271","author":"Clark","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.M030528_bib54","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1096\/fj.06-6025fje","article-title":"Sequential changes in the signal transduction responses of skeletal muscle following food deprivation","volume":"20","author":"de Lange","year":"2006","journal-title":"FASEB J."},{"key":"10.1194\/jlr.M030528_bib55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bbrc.2004.11.114","article-title":"Dietary polyunsaturated fatty acids enhance hepatic AMP-activated protein kinase activity in rats","volume":"326","author":"Suchankova","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.M030528_bib56","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1194\/jlr.M500438-JLR200","article-title":"Regulation of AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cells","volume":"47","author":"Fediuc","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M030528_bib58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2006.11.032","article-title":"Palmitate activates AMP-activated protein kinase and regulates insulin secretion from beta cells","volume":"352","author":"Wang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.M030528_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bbrc.2006.03.176","article-title":"Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice","volume":"344","author":"Sakakibara","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.M030528_bib60","doi-asserted-by":"crossref","first-page":"E1325","DOI":"10.1152\/ajpendo.00186.2006","article-title":"Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes","volume":"292","author":"Pelletier","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1194\/jlr.M030528_bib61","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.1074\/jbc.M608310200","article-title":"Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase","volume":"282","author":"Wu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib62","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1042\/BST0341370","article-title":"Protein phosphatases types 2Calpha and 2Cbeta in apoptosis","volume":"34","author":"Klumpp","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1194\/jlr.M030528_bib63","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bcp.2008.08.028","article-title":"AMPK activation by long chain fatty acyl analogs","volume":"76","author":"Za'tara","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M030528_bib74","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1210\/endo.143.8.8792","article-title":"Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase","volume":"143","author":"Barthel","year":"2002","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.M030528_bib75","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","article-title":"Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver","volume":"6","author":"Matsumoto","year":"2007","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.M030528_bib83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0026-0495(99)90007-0","article-title":"BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity","volume":"48","author":"Pill","year":"1999","journal-title":"Metabolism."},{"key":"10.1194\/jlr.M030528_bib85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/00365513.2011.559552","article-title":"Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis\u2013a pilot study","volume":"71","author":"Morken","year":"2011","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1194\/jlr.M030528_bib86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0005-2760(96)00138-5","article-title":"Thia fatty acids, metabolism and metabolic effects","volume":"1344","author":"Skrede","year":"1997","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M030528_bib87","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00041433-200206000-00010","article-title":"Metabolic effects of thia fatty acids","volume":"13","author":"Berge","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M030528_bib88","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.ATV.15.7.918","article-title":"Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta, beta\u2019-tetramethylhexadecanedioic acid (MEDICA 16)","volume":"15","author":"Russell","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M030528_bib89","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2337\/diab.37.12.1618","article-title":"Hypolipidemic, antiobesity, and hypoglycemic-hypoinsulinemic effects of beta,beta\u2019-methyl-substituted hexadecanedioic acid in sand rats","volume":"37","author":"Tzur","year":"1988","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M030528_bib90","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1021\/jm00129a010","article-title":"Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta\u2019,beta\u2019-tetrasubstituted, long-chain dioic acids","volume":"32","author":"Bar-Tana","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1194\/jlr.M030528_bib94","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1016\/S0021-9258(17)39489-9","article-title":"Inhibition of lipid synthesis by beta beta\u2019-tetramethyl-substituted, C14\u2013C22, alpha, omega-dicarboxylic acids in cultured rat hepatocytes","volume":"260","author":"Rose-Kahn","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib95","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1016\/S0021-9258(17)39488-7","article-title":"Inhibition of lipid synthesis by beta beta\u2019-tetramethyl-substituted, C14-C22, alpha, omega-dicarboxylic acids in the rat in vivo","volume":"260","author":"Bar-Tana","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib96","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0006-2952(01)00578-0","article-title":"Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators","volume":"61","author":"Hertz","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1194\/jlr.M030528_bib97","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.270.22.13470","article-title":"Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C\u2013III","volume":"270","author":"Hertz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M030528_bib98","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1210\/endo.131.4.1396307","article-title":"Tissue selective modulation of redox and phosphate potentials by beta,beta\u2019-methyl-substituted hexadecanedioic acid","volume":"131","author":"Kalderon","year":"1992","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.M030528_bib99","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0005-2760(90)90018-S","article-title":"Inhibition of rat liver acetyl-CoA carboxylase by beta, beta\u2019-tetramethyl-substituted hexadecanedioic acid (MEDICA 16)","volume":"1042","author":"Rose-Kahn","year":"1990","journal-title":"Biochim. Biophys. Acta."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520417699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520417699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M030528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T22:45:09Z","timestamp":1637448309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520417699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0022227520417699"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m030528","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}